1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Enzyme Chemistry Reagents Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Enzyme Chemistry Reagents Diagnostic Tests - Medical Devices Pipeline Assessment, 2015

Summary

GlobalData's Medical Devices sector report, “Enzyme Chemistry Reagents Diagnostic Tests - Medical Devices Pipeline Assessment, 2015" provides an overview of Enzyme Chemistry Reagents Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Enzyme Chemistry Reagents Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Enzyme Chemistry Reagents Diagnostic Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Enzyme Chemistry Reagents Diagnostic Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Enzyme Chemistry Reagents Diagnostic Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Enzyme Chemistry Reagents Diagnostic Tests - Medical Devices Pipeline Assessment, 2015
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 5
2 Introduction 6
2.1 Enzyme Chemistry Reagents Diagnostic Tests Overview 6
3 Products under Development 7
3.1 Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Stage of Development 7
3.2 Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Territory 8
3.3 Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Regulatory Path 9
3.4 Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Estimated Approval Date 10
4 Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products under Development by Companies 11
4.1 Enzyme Chemistry Reagents Diagnostic Tests Companies - Pipeline Products by Stage of Development 11
4.2 Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Stage of Development 12
5 Enzyme Chemistry Reagents Diagnostic Tests Companies and Product Overview 14
5.1 A/C Diagnostics LLC Company Overview 14
5.1.1 A/C Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 14
5.2 Alfa Wassermann Diagnostic Technologies, LLC Company Overview 16
5.2.1 Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 16
5.3 Analyticon Biotechnologies AG Company Overview 17
5.3.1 Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 17
5.4 Becton, Dickinson and Company Company Overview 35
5.4.1 Becton, Dickinson and Company Pipeline Products and Ongoing Clinical Trials Overview 35
5.5 BioMarin Pharmaceutical Inc. Company Overview 37
5.5.1 BioMarin Pharmaceutical Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
5.6 Imperial College London Company Overview 39
5.6.1 Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 39
5.7 NanoInk, Inc. Company Overview 42
5.7.1 NanoInk, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
5.8 University of Washington Company Overview 43
5.8.1 University of Washington Pipeline Products and Ongoing Clinical Trials Overview 43
5.9 Vital Diagnostics, Inc. Company Overview 44
5.9.1 Vital Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 44
6 Enzyme Chemistry Reagents Diagnostic Tests- Recent Developments 46
7 Appendix 47
7.1 Methodology 47
7.2 About GlobalData 49
7.3 Contact Us 49
7.4 Disclaimer 50

1.1 List of Tables
Table 1: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Stage of Development 7
Table 2: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Territory 8
Table 3: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Regulatory Path 9
Table 4: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Estimated Approval Date 10
Table 5: Enzyme Chemistry Reagents Diagnostic Tests Companies - Pipeline Products by Stage of Development 11
Table 6: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Stage of Development 12
Table 7: A/C Diagnostics LLC Pipeline Products and Ongoing Clinical Trials Overview 14
Table 8: Cysteine Enzymatic Assay - Product Status 14
Table 9: Cysteine Enzymatic Assay - Product Description 14
Table 10: Methionine Enzymatic Assay - Product Status 15
Table 11: Methionine Enzymatic Assay - Product Description 15
Table 12: Alfa Wassermann Diagnostic Technologies, LLC Pipeline Products and Ongoing Clinical Trials Overview 16
Table 13: ACE Axcel System - Enzymatic Creatinine Assay - Product Status 16
Table 14: ACE Axcel System - Enzymatic Creatinine Assay - Product Description 16
Table 15: Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 17
Table 16: a-HBDH Fluitest - Product Status 18
Table 17: a-HBDH Fluitest - Product Description 18
Table 18: ACP/ACP - P Lyophilisat - Product Status 18
Table 19: ACP/ACP - P Lyophilisat - Product Description 19
Table 20: ALP DGKC Fluitest - Product Status 19
Table 21: ALP DGKC Fluitest - Product Description 19
Table 22: ALP IFCC Fluitest - Product Status 20
Table 23: ALP IFCC Fluitest - Product Description 20
Table 24: AMYL - CNPG3 IFCC Fluitest - Product Status 20
Table 25: AMYL - CNPG3 IFCC Fluitest - Product Description 21
Table 26: AMYL IFCC Fluitest - Product Status 21
Table 27: AMYL IFCC Fluitest - Product Description 21
Table 28: AMYL-EPS Lyophilisat - Product Status 22
Table 29: AMYL-EPS Lyophilisat - Product Description 22
Table 30: CHE Fluitest - Product Status 22
Table 31: CHE Fluitest - Product Description 23
Table 32: CK MB Fluitest - Product Status 23
Table 33: CK MB Fluitest - Product Description 23
Table 34: CK MB Lyophilisat - Product Status 24
Table 35: CK MB Lyophilisat - Product Description 24
Table 36: CK NAC Lyophilisat - Product Status 24
Table 37: CK NAC Lyophilisat - Product Description 25
Table 38: Fluitest AMYL DGKC - Product Status 25
Table 39: Fluitest AMYL DGKC - Product Description 25
Table 40: Fluitest CK NAc - Product Status 26
Table 41: Fluitest CK NAc - Product Description 26
Table 42: Fluitest CREA PAP - Product Status 26
Table 43: Fluitest CREA PAP - Product Description 27
Table 44: Fluitest GGT - Product Status 27
Table 45: Fluitest GGT - Product Description 27
Table 46: Fluitest GLDH - Product Status 28
Table 47: Fluitest GLDH - Product Description 28
Table 48: Fluitest GLU HK 100+1 - Product Status 28
Table 49: Fluitest GLU HK 100+1 - Product Description 29
Table 50: Fluitest GLU HK 5+1 - Product Status 29
Table 51: Fluitest GLU HK 5+1 - Product Description 29
Table 52: Fluitest GOT AST - Product Status 30
Table 53: Fluitest GOT AST - Product Description 30
Table 54: Fluitest GPT ALT - Product Status 31
Table 55: Fluitest GPT ALT - Product Description 31
Table 56: GGT Lyophilisat - Product Status 31
Table 57: GGT Lyophilisat - Product Description 32
Table 58: GOT AST Lyophilisat - Product Status 32
Table 59: GOT AST Lyophilisat - Product Description 32
Table 60: GPT ALT Lyophilisat - Product Status 33
Table 61: GPT ALT Lyophilisat - Product Description 33
Table 62: LDH-P Fluitest - Product Status 34
Table 63: LDH-P Fluitest - Product Description 34
Table 64: Becton, Dickinson and Company Pipeline Products and Ongoing Clinical Trials Overview 35
Table 65: BD Phoenix - Dual AST Panel - Product Status 35
Table 66: BD Phoenix - Dual AST Panel - Product Description 36
Table 67: BioMarin Pharmaceutical Inc. Pipeline Products and Ongoing Clinical Trials Overview 37
Table 68: Sensi-Pro Assay - Product Status 37
Table 69: Sensi-Pro Assay - Product Description 38
Table 70: Imperial College London Pipeline Products and Ongoing Clinical Trials Overview 39
Table 71: Lipase Enzymatic Assay - Product Status 39
Table 72: Lipase Enzymatic Assay - Product Description 39
Table 73: Protease Enzymatic Assay - Product Status 40
Table 74: Protease Enzymatic Assay - Product Description 40
Table 75: Transferase Enzymatic Assay - Product Status 40
Table 76: Transferase Enzymatic Assay - Product Description 41
Table 77: NanoInk, Inc. Pipeline Products and Ongoing Clinical Trials Overview 42
Table 78: Human Matrix Metalloproteinase Assay Kit - Product Status 42
Table 79: Human Matrix Metalloproteinase Assay Kit - Product Description 42
Table 80: University of Washington Pipeline Products and Ongoing Clinical Trials Overview 43
Table 81: Laboratory Reagent - Heart Disease - Product Status 43
Table 82: Laboratory Reagent - Heart Disease - Product Description 43
Table 83: Vital Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 44
Table 84: Eon 100 Automated Chemistry Analyzer - Lipase Assay - Product Status 44
Table 85: Eon 100 Automated Chemistry Analyzer - Lipase Assay - Product Description 44
Table 86: Eon 300 Automated Chemistry Analyzer - Lipase Assay - Product Status 45
Table 87: Eon 300 Automated Chemistry Analyzer - Lipase Assay - Product Description 45
Table 88: Glossary 48

1.2 List of Figures
Figure 1: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Stage of Development 7
Figure 2: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Territory 8
Figure 3: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Regulatory Path 9
Figure 4: Enzyme Chemistry Reagents Diagnostic Tests - Pipeline Products by Estimated Approval Date 10

Companies mentioned
A/C Diagnostics LLC
Alfa Wassermann Diagnostic Technologies, LLC
Analyticon Biotechnologies AG
Becton, Dickinson and Company
BioMarin Pharmaceutical Inc.
Imperial College London
NanoInk, Inc.
University of Washington
Vital Diagnostics, Inc.

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.